Evidence map›Paper›PMID 30224471›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Structural mechanism of Myb-MuvB assembly.

Keelan Z Guiley, Audra N Iness, Siddharth Saini, Sarvind Tripathi, Joseph S Lipsick, Larisa Litovchick, Seth M Rubin

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Keelan Z GuileyDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064.
Audra N InessDivision of Hematology, Oncology and Palliative Care and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298.
Siddharth SainiDivision of Hematology, Oncology and Palliative Care and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298.
Sarvind TripathiDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064.ORCID 0000-0002-6959-0577
Joseph S LipsickDepartment of Pathology, Stanford University, Stanford, CA 94305-5324.
Larisa LitovchickDivision of Hematology, Oncology and Palliative Care and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298; larisa.litovchick@vcuhealth.org srubin@ucsc.edu.
Seth M RubinDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064; larisa.litovchick@vcuhealth.org srubin@ucsc.edu.
University of California, Santa Cruz · USVirginia Commonwealth University · USStanford University · US

Funding

Molecular Mechanisms Regulating the Retinoblastoma Protein FamilyR01CA132685 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI RUBIN, SETH MICHAEL · 2008 to 2017
$3.0M
Biology of the Myb-MuvB Oncoprotein-Tumor Suppressor Protein ComplexR01CA128836 · NCI · STANFORD UNIVERSITY · PI LIPSICK, JOSEPH STEVEN · 2007 to 2016
$2.6M
DYRK1A signaling in control of cell growth, proliferation and DNA damage repairR01CA188571 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI LITOVCHICK, LARISA · 2015 to 2019
$2.0M
Structural Mechanisms Controlling Cell-Cycle Gene ExpressionR01GM124148 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI RUBIN, SETH MICHAEL · 2018 to 2021
$1.5M
Cell cycle control through DREAM and MMB complexesF31CA206244 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI GUILEY, KEELAN ZACHARY · 2016 to 2017
$77k
NCI NIH HHS F31 CA206244NCI NIH HHS R01 CA128836NCI NIH HHS R01 CA132685NCI NIH HHS R01 CA188571NIGMS NIH HHS R01 GM124148
6 · The paper itself

Abstract

The MuvB transcriptional regulatory complex, which controls cell-cycle-dependent gene expression, cooperates with B-Myb to activate genes required for the G2 and M phases of the cell cycle. We have identified the domain in B-Myb that is essential for the assembly of the Myb-MuvB (MMB) complex. We determined a crystal structure that reveals how this B-Myb domain binds MuvB through the adaptor protein LIN52 and the scaffold protein LIN9. The structure and biochemical analysis provide an understanding of how oncogenic B-Myb is recruited to regulate genes required for cell-cycle progression, and the MMB interface presents a potential therapeutic target to inhibit cancer cell proliferation.

Indexed as

Cell CycleCell Cycle ProteinsMultiprotein ComplexesNeoplasm ProteinsNeoplasmsNuclear ProteinsTrans-ActivatorsTumor Suppressor ProteinsCell LineCrystallography, X-RayHumansProtein DomainsCell Cycle ProteinsLIN9 protein, humanMultiprotein ComplexesMYBL2 protein, humanNeoplasm ProteinsNuclear ProteinsTrans-ActivatorsTumor Suppressor Proteinscell cycleDREAMMuvBMybtranscription factor

Identifiers

PMID30224471
PMCPMC6176624
OpenAlexW2890913929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.